Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia
Previous studies have shown that erythropoietin (EPO) is neuroprotective in both in vivo and in vitro models of hypoxia ischemia. However these studies hold limited clinical translations because the underlying mechanism remains unclear and the key molecules involved in EPO-induced neuroprotection ar...
Main Authors: | Rhonda Souvenir, Nancy Fathali, Robert P. Ostrowski, Tim Lekic, John H. Zhang, Jiping Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-10-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996111001896 |
Similar Items
-
Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia
by: Feng Zhang, et al.
Published: (2007-01-01) -
miR-122 regulates the JAK-STAT signalling pathway by down-regulating EPO in the mammary gland during Streptococcus agalactiae-induced mastitis
by: Junhua Pu, et al.
Published: (2020-12-01) -
The utility of testing erythropoietin level in polycythemia diagnosis
by: Abdellatif Ismail, et al.
Published: (2023-12-01) -
Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity
by: Amalia Merelli, et al.
Published: (2019-07-01) -
The Role of Erythropoietin in Preventing Anemia in the Premature Neonate
by: Oana Cristina Costescu, et al.
Published: (2023-11-01)